Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Bobulsky Susan sold 3,000 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Aug 10, 2026 · Filed Aug 12, 2026

On Aug 10, 2026, Bobulsky Susan (Chief Commercial Officer, MRD) sold 3,000 Adaptive Biotechnologies Corporation shares at US$25.00 for US$75,000 under a trading plan, leaving 396,989 shares. Filed Aug 12, 2026 (Form 4).

Sold
3,000 shares
Price
US$25.00
Value
US$75,000
Holding after
396,989 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer, MRD

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockSale3,000US$25.00396,989Direct

Source

View original at SEC

Related